SOURCE: Viveve Medical, Inc.

Viveve Medical, Inc. Logo

October 23, 2014 08:28 ET

Viveve Announces Ticker Symbol Change to VIVMF

SUNNYVALE, CA--(Marketwired - October 23, 2014) - Viveve Medical, Inc. ("Viveve") (PINKSHEETS: VIVMF), a company focused on women's health, today announced that, effective October 22, 2014, its common stock commenced trading under the new ticker symbol "VIVMF" on the over-the-counter market. Since changing its name in September as a result of the merger with PLC Systems, Inc., the Company has traded on the OTC under the ticker symbol "PLCSD."

About Viveve

Viveve, Inc., the operating subsidiary of Viveve Medical, Inc., is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the Viveve® System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue. The Viveve System treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth, which can result in a decrease in sexual function and physical sensation. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontinence or stretch marks. The Viveve Treatment uses patented, reverse-thermal gradient radiofrequency technology to tighten the tissues of the vaginal introitus (opening) and requires only a 30-minute out-patient treatment in a physician's office. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. It is currently not available for sale in the U.S.

Safe Harbor Statement

All statements in this press release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this press release on its current expectations, the information on which such expectations were based may change. These forward looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are to be detailed in our periodic and current reports available for review at www.sec.gov. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Viveve, Viveve System, Viveve Treatment and Viveve Procedure are registered trademarks of Viveve, Inc.

Contact Information

  • Contact:
    Investor Relations
    Booke and Company Inc.
    600 Third Ave.
    New York, NY 10016
    212-490-9095
    admin@bookeandco.com